Company
Protagonist Therapeutics
Protagonist Therapeutics is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.
Latest on Protagonist Therapeutics
- [via Johnson & Johnson]
- 13F: Moody Aldrich Partners Llc holds Protagonist Therapeutics ($6M)
- 13F: Johnson & Johnson holds Protagonist Therapeutics ($345M)
Connections
5 entities linked to Protagonist Therapeutics across the news graph.